| Literature DB >> 35497437 |
Intissar Hamdi1, Intidhar Bkhairia2, Andreas Roodt3, Thierry Roisnel4, Moncef Nasri2, Houcine Naïli1.
Abstract
A slow evaporation method has permitted the crystallization of two novel crystals of (2-aminomethyl)pyridindiumdihalide C6H10N2,2Br (1) and C6H10N2,2Cl·H2O (2). The structures of the prepared compounds (1) and (2) were elucidated by single-crystal X-ray diffraction which revealed that they crystallize, respectively, with triclinic and monoclinic symmetries. Their crystal packing was stabilized by non-covalent interactions, including N-H⋯Br, C-H⋯Br, N-H⋯Cl, O-H⋯Cl and N-H⋯O hydrogen bonds. 3-D Hirshfeld surface analysis followed by 2-D fingerprint schemes gives insights into the intermolecular interactions in the crystalline structure. Furthermore, the FT-IR spectroscopy of these two compounds was carried out. The synthesized products were also screened for in vitro antioxidant and antimicrobial activities, which reveals their favourable antioxidant activities against 1,1-diphenyl-2-picrylhydrazyl (DPPH) as well as the discolouration of β-carotene. This journal is © The Royal Society of Chemistry.Entities:
Year: 2020 PMID: 35497437 PMCID: PMC9049630 DOI: 10.1039/c9ra09294c
Source DB: PubMed Journal: RSC Adv ISSN: 2046-2069 Impact factor: 4.036
Crystallographic data for C6H10N2,2Br and C6H10N2,2Cl·H2O
| Empirical formula | C6H10N2,2Br | C6H10N2,2Cl·H2O |
| Formula weight (g mol−1) | 269.98 | 199.08 |
| Temperature (K) | 150 | 293 |
| Wavelength (Å) | 0.71073 | 0.71073 |
| Crystal system | Triclinic | Monoclinic |
| Space group |
|
|
|
| 6.6560 (9) | 16.678 (5) |
|
| 7.7563 (10) | 7.107 (5) |
|
| 9.1524 (12) | 15.865 (5) |
|
| 76.320 (4) | 90 |
|
| 80.652 (4) | 97.397 (5) |
|
| 82.187 (5) | 90 |
|
| 450.65 (10) | 1864.8 (15) |
|
| 2 | 8 |
| Calculated density (mg m−3) | 1.990 | 1.418 |
| Absorption coefficient (mm−1) | 8.93 | 0.65 |
|
| 260 | 832 |
| Crystal size (mm3) | 0.33 × 0.27 × 0.16 | 0.33 × 0.27 × 0.16 |
| Habit-color | Plate-colourless | Block-yellow |
|
| 3.1–27.5 | 1.2–28.4 |
|
| 0.041 | 0.041 |
|
| 0.103 | 0.811 |
|
| 0.240 | 0.902 |
| Index ranges | −8 ≤ | −22 ≤ |
| −10 ≤ | −9 ≤ | |
| −11 ≤ | −21 ≤ | |
| Refinement method | Full-matrix least-squares on | Full-matrix least-squares on |
|
| 0.020 | 0.025 |
| w | 0.046 | 0.092 |
| Goodness-of-fit on | 1.05 | 1.19 |
| Data/restraints/parameters | 2065/0/104 | 4666/0/215 |
| Extinction coefficient | 0.075 (3) | 0.066 (5) |
| Δ | −0.75 | −0.40 |
| Δ | 0.65 | 0.39 |
Selected bond distances (Å) and angles (°) for (1) and (2)
|
| |||
| N1–C5 | 1.343 (3) | C2–C3 | 1.383 (3) |
| N1–C1 | 1.344 (3) | C5–C4 | 1.384 (3) |
| N2–C6 | 1.492 (3) | C5–C6 | 1.505 (3) |
| C2–C1 | 1.376 (3) | C4–C3 | 1.387 (3) |
| C5–N1–C1 | 123.64 (17) | C5–C4–C3 | 119.14 (19) |
| C1–C2–C3 | 119.14 (19) | C2–C3–C4 | 120.29 (19) |
| N1–C5–C4 | 118.67 (17) | N1–C1–C2 | 119.11 (19) |
| N1–C5–C6 | 116.61 (17) | N2–C6–C5 | 111.10 (16) |
| C4–C5–C6 | 124.71 (18) | ||
|
| |||
| N3–C7 | 1.3431 (17) | C2–C4 | 1.3805 (18) |
| N3–C1 | 1.3471 (16) | C2–C10 | 1.5054 (17) |
| N4–C11 | 1.3431 (17) | C3–C5 | 1.3914 (18) |
| N4–C2 | 1.3483 (16) | C4–C9 | 1.3967 (18) |
| N5–C10 | 1.4745 (17) | C4–C9 | 1.3967 (18) |
| N6–C12 | 1.4777 (18) | C6–C11 | 1.376 (2) |
| C1–C3 | 1.3856 (18) | C6–C9 | 1.3898 (19) |
| C1–C12 | 1.5089 (17) | C7–C8 | 1.3780 (19) |
| C7–N3–C1 | 123.10 (11) | C2–C4–C9 | 119.67 (12) |
| C11–N4–C2 | 123.18 (11) | C3–C5–C8 | 119.86 (12) |
| N3–C1–C3 | 118.64 (11) | C11–C6–C9 | 118.46 (12) |
| N3–C1–C12 | 116.49 (11) | N3–C7–C8 | 120.09 (12) |
| C3–C1–C12 | 124.82 (12) | C7–C8–C5 | 118.64 (12) |
| N4–C2–C4 | 118.49 (11) | C6–C9–C4 | 119.97 (12) |
| N4–C2–C10 | 115.00 (11) | N5–C10–C2 | 112.67 (11) |
| C4–C2–C10 | 126.46 (12) | N4–C11–C6 | 120.22 (12) |
| C1–C3–C5 | 119.65 (12) | N6–C12–C1 | 111.65 (11) |
Hydrogen bonding geometry (Å, °)a
| D–H (Å) | H⋯A (Å) | D⋯A (Å) | D–H⋯A (°) | |
|---|---|---|---|---|
|
| ||||
| N1–H1⋯Br2a | 0.86 | 2.39 | 3.2397 (17) | 170 |
| N2–H2A⋯Br1b | 0.89 | 2.50 | 3.2808 (17) | 146 |
| N2–H2B⋯Br1c | 0.89 | 2.54 | 3.2378 (18) | 135 |
| N2–H2C⋯Br2 | 0.89 | 2.62 | 3.3393 (17) | 138 |
|
| ||||
| N3–H3⋯Cl2 | 0.86 | 2.17 | 3.0296 (13) | 172 |
| N4–H4⋯Cl3 | 0.86 | 2.17 | 3.0241 (13) | 177 |
| N5–H5A⋯Cl1d | 0.89 | 2.38 | 3.1809 (15) | 150 |
| N5–H5A⋯Cl3e | 0.89 | 2.96 | 3.3897 (15) | 112 |
| N5–H5B⋯Cl2f | 0.89 | 2.36 | 3.147 (2) | 148 |
| N5–H5B⋯O55 | 0.89 | 2.60 | 3.0603 (19) | 113 |
| N5–H5C⋯Cl4 | 0.89 | 2.38 | 3.1705 (17) | 148 |
| N6–H6A⋯Cl4g | 0.89 | 2.38 | 3.1913 (15) | 151 |
| N6–H6B⋯O56 | 0.89 | 2.38 | 2.9383 (18) | 121 |
| N6–H6B⋯Cl1 | 0.89 | 2.38 | 3.2826 (18) | 132 |
| N6–H6C⋯Cl3h | 0.89 | 2.38 | 3.118 (2) | 158 |
| O56–H118⋯Cl1i | 0.89 | 2.46 | 3.1999 (15) | 173 (3) |
| O55–H120⋯Cl4g | 0.89 | 2.48 | 3.2039 (16) | 163 (3) |
| O56–H119⋯Cl1j | 0.84 (3) | 2.39 (3) | 3.212 (3) | 168 (2) |
| O55–H121⋯Cl4k | 0.86 (3) | 2.35 (3) | 3.190 (2) | 166 (3) |
Symmetry codes: (a) −x + 2, −y + 1, −z + 1; (b) −x + 2, −y, −z + 1; (c) x + 1, y, z; (d) −x + 1, y + 1/2, −z − 1/2; (e) x, −y + 1/2, z − 1/2; (f) −x + 1, −y, −z; (g) −x + 1, y − 1/2, −z − 1/2; (h) −x + 1, −y + 1, −z; (i) −x + 2, y + 1/2, −z − 1/2; (j) x, y + 1, z; (k) x, y − 1, z.
Fig. 1IR spectra of C6H10N2,2Br (a), and C6H10N2,2Cl·H2O (b).
Fig. 2(A) The asymmetric unit of compound (1), showing the atom-labeling scheme. Displacement ellipsoids are drawn at 50% probability level. The dashed line represents the possible hydrogen bond. (B) The crystal packing of the title salt (1) projected onto bc plane. The N–H⋯Br and C–H⋯Br hydrogen bonds are shown as dashed lines. (C) The asymmetric unit of compound (2), showing the atom-labeling scheme. Displacement ellipsoids are drawn at 50% probability level. The dashed lines represent the possible hydrogen bonds. (D) A view of the three-dimensional supramolecular architecture of (2), formed by N–H⋯Cl, O–H⋯Cl and N–H⋯O hydrogen bond interactions.
Fig. 3(A) Hirshfeld surface mapped over dnorm (a) of the asymmetric unit and 2D fingerprint plots (b) of the C6H10N2,2Br compound. (B) Hirshfeld surface mapped over dnorm (a) of the asymmetric unit and 2D fingerprint plots (b) of the C6H10N2,2Cl·H2O compound.
Fig. 4(A) 2D fingerprint plots of the C6H10N2,2Br compound. (B) 2D fingerprint plots of the C6H10N2,2Cl·H2O compound.
Fig. 5(A) ABTS radical scavenging of compounds (1) and (2) at different concentration. (B) Reducing power of the synthesized compounds (1) and (2) at different concentrations. C) β-Carotene bleaching inhibition activity of the synthesized compounds (1) and (2) at different concentrations. (D) DPPH free radical-scavenging activity of compounds (1) and (2) at different concentrations.
Antibacterial activity of the synthesized compounds (1) and (2) using agar disc diffusion
|
|
|
|
|
| |
|---|---|---|---|---|---|
| IZD (1) | 16 | 10 | 10 | 22 | 20 |
| IZD (2) | 26 | 18 | 16 | 30 | 22 |
| IZD (bacitracin) | 19 | — | 25 | 22 | 9 |
| IZD (gentamicin) | 14 | 20 | 18 | 16 | 14 |